Leonard Saltz
机构: Professor of Medicine, Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center
每年引用次数
引用次数
引用: 87,979
H-指数: 150
I10-指数 : 438
出版物: 863
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Leonard B. Saltz , Stephen Clarke , Eduardo Díaz-Rubio , Werner Scheithauer
Journal of Clinical Oncology 26 ( 12) 2013 -2019
3,513
2008
Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines
Daniel G. Haller , Jim Cassidy , Stephen J. Clarke , David Cunningham
Journal of Clinical Oncology 26 ( 13) 2118 -2123
249
2008
Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803
Leonard B. Saltz , Robert J. Mayer , Heidi Nelson , Renaud Whittom
Journal of Clinical Oncology 26 ( 25) 4109 -4115
201
2008
Irinotecan in the Treatment of Colorectal Cancer
Charles Fuchs , Edith P Mitchell , Paulo M Hoff
Humana Press, Totowa, NJ 513 -524
195
2002
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.
Ghassan K. Abou-Alfa , Philip Johnson , Jennifer J. Knox , Marinela Capanu
JAMA 304 ( 19) 2154 -2160
514
2010
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum.
Melanie E. Royce , Eric K. Rowinsky , Paulo M. Hoff , John Coyle
Investigational New Drugs 22 ( 1) 53 -61
18
2004
Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
Ki Y. Chung , Ira Gore , Lawrence Fong , Alan Venook
Journal of Clinical Oncology 28 ( 21) 3485 -3490
189
2010
Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer
Diane Lauren Reidy , Efsevia Vakiani , Marwan G. Fakih , Muhammad Wasif Saif
Journal of Clinical Oncology 28 ( 27) 4240 -4246
118
2010
Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies
Herbert I. Hurwitz , Leonard B. Saltz , Eric Van Cutsem , James Cassidy
Journal of Clinical Oncology 29 ( 13) 1757 -1764
168
2011
Addition of Octreotide Functional Imaging to Cross-Sectional Computed Tomography or Magnetic Resonance Imaging for the Detection of Neuroendocrine Tumors: Added Value or an Anachronism?
Diane L. Reidy-Lagunes , Marc J. Gollub , Leonard B. Saltz
Journal of Clinical Oncology 29 ( 3) e74 -e75
24
2011
Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803
Monica M. Bertagnolli , Mark Redston , Carolyn C. Compton , Donna Niedzwiecki
Journal of Clinical Oncology 29 ( 23) 3153 -3162
131
2011
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
Kyle Holen , Leonard B. Saltz , Ellen Hollywood , Konrad Burk
Investigational New Drugs 26 ( 1) 45 -51
189
2008
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer
William P. Tew , Delia Radovich , Eileen O’Reilly , Gary Schwartz
Investigational New Drugs 27 ( 4) 366 -373
4
2009
Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas
Efsevia Vakiani , Manickam Janakiraman , Ronglai Shen , Rileen Sinha
Journal of Clinical Oncology 30 ( 24) 2956 -2962
297
2012
Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial
Keisuke Kosumi , Tsuyoshi Hamada , Sui Zhang , Li Liu
European Journal of Cancer 111 82 -93
6
2019
Dietary Glycemic Load and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings From CALGB 89803
Jeffrey A. Meyerhardt , Kaori Sato , Donna Niedzwiecki , Cynthia Ye
Journal of the National Cancer Institute 104 ( 22) 1702 -1711
107
2012
Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
Kimmie Ng , Jeffrey A. Meyerhardt , Andrew T. Chan , Kaori Sato
Journal of the National Cancer Institute 107 ( 1) 345 -345
84
2015
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer
Matthew S. Katz , Bruce D. Minsky , Leonard B. Saltz , Elyn Riedel
International Journal of Radiation Oncology Biology Physics 62 ( 5) 1363 -1370
69
2005
Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters
Andreas M. Hötker , Lisa Tarlinton , Yousef Mazaheri , Kaitlin M. Woo
European Radiology 26 ( 12) 4303 -4312
42
2016
Evaluation of 18F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: A prospective analysis
Tobias Leibold , Timothy J. Akhurst , David B. Chessin , Henry W. Yeung
Annals of Surgical Oncology 18 ( 10) 2783 -2789
35
2011